If you're hunting for growth stock exposure without having to pick individual winners, exchange-traded funds make life easier. You get instant diversification, low costs, and the ability to trade throughout the day. Two ETFs dominate the large-cap growth conversation: Vanguard Russell 1000 Growth ETF (VONG) and Schwab U.S. Large-Cap Growth ETF (SCHG). Both target big U.S. companies with growth characteristics, but they approach that mission differently. And in 2026's market environment, with money sloshing between sectors like it's musical chairs, those differences actually matter.
Breaking Down What You're Actually Buying
VONG tracks the Russell 1000 Growth Index, which sounds fancy but basically means it owns about 500 large-cap U.S. companies that exhibit above-average growth potential. Its portfolio leans heavily into technology, consumer discretionary, and healthcare. The top holdings read like a who's who of the smartphone-and-cloud era: Apple Inc. (AAPL), Microsoft Corp. (MSFT), and Amazon.com Inc. (AMZN). If you believe mega-cap tech will continue running the table, VONG delivers that exposure in concentrated form.
SCHG takes a slightly different path. It follows the Dow Jones U.S. Large-Cap Growth Total Stock Market Index and holds around 120 names. That's fewer stocks than VONG, but SCHG spreads its bets differently. It still owns plenty of technology giants like Alphabet Inc. (GOOG) and Nvidia Corp. (NVDA), but the weighting toward mega-cap tech isn't quite as extreme. You get more exposure to mid-sized growth companies, which can be a feature or a bug depending on what you're trying to accomplish.
The Sector Concentration Question
Here's where things get interesting. VONG allocates roughly 50% of its portfolio to technology stocks. That's a lot of eggs in one basket, even if that basket is filled with profitable companies generating massive cash flows. SCHG's technology allocation sits closer to 40%, which still qualifies as tech-heavy but leaves more room for other sectors to contribute.
SCHG also carries higher weightings in healthcare and consumer discretionary mid-caps. This matters because we're watching a real-time sector rotation play out in early 2026. Investors are rotating out of the mega-cap tech names that dominated recent years and into small-caps, mid-caps, energy, and industrials. If that trend continues, VONG's concentrated tech exposure could translate to higher volatility. SCHG's broader sector mix might offer a smoother ride, though potentially at the cost of missing some upside if tech roars back.




